Statement regarding Smiths Medical

RNS Number : 8864K

Smiths Group PLC

02 August 2013

 

 

News Release

London, 2 August 2013

For immediate release

Statement regarding Smiths Medical

Further to the announcement made on 31 May 2013 about a preliminary approach for the Medical division, Smiths Group announces that it has not proved possible to reach agreement with the potential counterparty on acceptable terms for a transaction.  Discussions have therefore been terminated.

In reaching this conclusion, the Board has taken full account of the quality and highly cash generative nature of Smiths Medical, both standalone and in the context of the Group as a whole.

ENDS

Investor Relations

Peter Durman: [phone]

Media Relations

Anthony Cardew - Cardew Group: [phone] / [phone]

Colin McSeveny: [phone]

Smiths Group

Smiths is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). A world leader in the practical application of advanced technologies, Smiths Group delivers products and services for the threat & contraband detection, medical devices, energy and communications markets worldwide. Our products and services make the world safer, healthier and more productive. Smiths Group employs around 23,000 people in over 50 countries. For more information visit www.smiths.com

 

END

 

 

OTTPTMATMBBMBBJ